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Abstract
Background: The relationship between anthropometric indices and risk of basal cell carcinoma
(BCC) is largely unknown. We aimed to examine the association between anthropometric
measures and development of BCC and to demonstrate whether adherence to World Health
Organisation guidelines for body mass index, waist circumference, and waist/hip ratio was
associated with risk of BCC, independent of sun exposure.
Methods: Study participants were participants in a community-based skin cancer prevention trial
in Nambour, a town in southeast Queensland (latitude 26°S). In 1992, height, weight, and waist and
hip circumferences were measured for all 1621 participants and weight was remeasured at the end
of the trial in 1996. Prevalence proportion ratios were calculated using a log-binomial model to
estimate the risk of BCC prior to or prevalent in 1992, while Poisson regression with robust error
variances was used to estimate the relative risk of BCC during the follow-up period.
Results: At baseline, 94 participants had a current BCC, and 202 had a history of BCC. During the
5-year follow-up period, 179 participants developed one or more new BCCs. We found no
significant association between any of the anthropometric measures or indices and risk of BCC
after controlling for potential confounding factors including sun exposure. There was a suggestion
that short-term weight gain may increase the risk of developing BCC for women only.
Conclusion: Adherence to World Health Organisation guidelines for body mass index, waist
circumference and waist/hip ratio is not significantly associated with occurrence of basal cell
carcinomas of the skin.
Background
To date only two previous studies have investigated the
association between anthropometric measures and basal
cell carcinoma (BCC) [1,2]. Sahl et al (1995) in a small
case-control study based on 46 cases reported a positive
association between weight and BCC, whilst Milan et al
(2003) in a nested case-control study of disease-discord-
ant same-sex twin pairs based on 333 cases of BCC, found
no relationship between BMI and risk of BCC. In neither
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study did the authors consider potential confounders
such as phenotypic characteristics and sun exposure.
Anthropometric measures such as height, weight and
body mass index (BMI) are associated with the develop-
ment of certain malignancies [3]. Increasing height has
been associated with increased risk of cancer of the breast,
colon and prostate [3-5]. Obesity has been consistently
associated with an increased risk of cancers of the colon,
breast (in postmenopausal women), endometrium, kid-
ney, oesophagus, and gastric cardia [6].
A number of hypotheses have been put forward to explain
the associations of anthropometric measures and cancer.
The first is that increasing height and/or weight correlate
directly with the total number of cells that can undergo
malignant transformation [7]. The second is that both
adult height and cancer incidence are directly related to
caloric intake in early life, implicating positive energy bal-
ance. Animal studies have found that reduced caloric
intake during development reduces the future risk of
malignancy [8,9] and one study in humans also sup-
ported this hypothesis [10]. The association between
height, weight and cancer may be mediated via alterations
in the metabolism of endogenous hormones [11,12].
Obesity may also result in long-term storage of toxins,
medications and vitamins in adipose tissue [13] or mod-
ify immune function [14].
We examined the association between anthropometric
measures and indices and risk of BCC in a representative
sample of people aged 25 to 75 years living in the town-
ship of Nambour, Queensland, who were followed up
prospectively for a period of 4.5 years from early 1992 to
late 1996. Specifically we aimed to demonstrate whether
or not adherence to World Health Organisation guide-
lines for BMI, waist circumference and waist/hip ratio was
associated with development of BCC, independent of sun
exposure.
Methods
Participants were 1621 residents of Nambour, a subtropi-
cal town in South-East Queensland (latitude 26°S), who
were originally randomly selected from the electoral roll
(enrolment is compulsory) and who were participating in
the Nambour Skin Cancer Prevention Trial between 1992
and 1996 to evaluate the preventive effects of sunscreen
use and/or beta-carotene supplementation. Detailed
descriptions of the trial and its outcomes are reported else-
where [15,16]. Participants gave written informed consent
at the beginning of the trial. At baseline in 1992, height,
weight, waist and hip circumference were measured.
Weight was re-measured at the end of the field trial
(1996). In addition, personal information was collected
at interview including skin colour, eye colour, hair colour,
propensity of the skin to sunburn and number of sun-
burns, as well as outdoor exposure during occupation and
leisure (classified as mainly indoors or outdoors, or a mix-
ture of indoors and outdoors). All anthropometric meas-
urements were obtained by trained nurses or nutritionists
using standard procedures.
Dermatologists performed full skin examinations of par-
ticipants in 1992 and again in 1994 and 1996 for the
majority of participants, including some who had other-
wise withdrawn. In 1996, 124 people who had missed the
1994 examination were again examined by a dermatolo-
gist. Every participant had at least one follow-up examina-
tion with a dermatologist in either 1994 or 1996. All
lesions clinically diagnosed as BCC were biopsied for his-
tologic confirmation by a single dermatopathologist. In
addition, participants were followed-up every 3 months
and any new cancers treated by the participant's General
Practitioner were documented and later validated against
histological records. Finally and with participants' con-
sent, independent pathology laboratories throughout
Queensland provided reports on all skin cancers diag-
nosed during the entire trial period for cross-checking.
History of BCC or squamous cell carcinoma (SCC) prior
to 1986 was obtained from a prevalence survey of skin
cancer and actinic skin damage conducted in December
1986 [17], and BCCs and SCCs treated between 1986 and
1992 were monitored via surveys conducted between
1986 and 1992 [18,19].
The study was approved by the Queensland Institute of
Medical Research ethics committee and abided by the
Declaration of Helsinki on research on human subjects.
Data analysis
Weight and height were expressed as quartiles of the dis-
tribution for the entire at-risk cohort, while BMI, waist cir-
cumference and waist/hip ratios were classified using
World Health Organisation (WHO) definitions of obes-
ity. The WHO BMI classification for adults was based on
results of studies that linked morbidity and mortality to
body weight [20] (<18.5 "underweight"; 18.5–24.9 "nor-
mal weight"; 25–29.9 "overweight"; and ≥ 30 obese).
Waist circumference was categorised using the sex-specific
WHO cut-offs for risk of metabolic complications in Cau-
casians [21]. Waist circumference measurements of < 94
cm for males and <80 cm for females were classified as
'desirable'; 94–102 cm for males and 80–88 cm for
females were classified as 'increased obesity-associated
risk'; and >102 cm for males and >88 cm for females were
classified as 'substantially increased obesity-associated
risk'. Waist/hip ratio was divided into two sex-specific cat-
egories, since high ratios (>1.0 in men and > 0.85 in
women) is taken to indicate abdominal fat accumulation
[22].BMC Cancer 2006, 6:82 http://www.biomedcentral.com/1471-2407/6/82
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Two outcomes were examined: presence of one or more
BCCs prior to the baseline survey or prevalent at the base-
line survey in 1992 ('prevalent' BCC); and incidence of
one or more histologically confirmed BCCs between the
baseline survey in 1992 and 1996 ('incident' BCC).
Prevalence proportion ratios (PPR) with 95% confidence
intervals (95% CI) were calculated as estimates of the risk
of prevalent BCC associated with weight quartiles, height
quartiles, BMI category, waist circumference and waist/
hip ratio category, using the lowest category of each as the
reference category. A multiplicative generalized linear
model with logarithmic link function and binomial distri-
bution function [23] was used to adjust for age and poten-
tial confounders such as education, smoking status, skin
colour, hair colour, skin type, occupation type, leisure
type, number of painful sunburns in lifetime, and use of
hormone replacement therapy. Only those factors that
changed the point estimate by >10% were included in the
final models. Occupational exposure was taken to indi-
cate cumulative sun exposure and leisure-time exposure,
as indicating an irregular sun exposure pattern. Height
was assessed as a potential confounder in the analyses for
weight, waist circumference and waist/hip ratio catego-
ries, but it did not change the point estimate by >10% and
so was not included in the final models.
To assess anthropometric measures at baseline in relation
to incidence of BCC 1992–1996, relative risks (RR) for the
binary outcome (new BCC 1992–1996 or no BCC ever)
associated with weight quartiles, height quartiles, BMI,
waist circumference and waist/hip ratio categories at base-
line were calculated using a Poisson regression with
robust error variance [24]. Multivariate Poisson regression
was used to adjust for age and history of BCC, and other
potential confounders as described for the analyses of
prevalent BCC. Effect modification for both outcomes
(prevalent and incident BCC) was assessed by comparing
stratum-specific point estimates. If the stratum-specific
point estimates appeared to differ, multiplicative terms
were entered in to the model. A p-value of <0.05 for the
multiplicative term was interpreted as significant effect
modification. We also tested for homogeneity of the stra-
tum-specific point estimate using chi-square test for
homogeneity [25].
Possible relationship between change in weight 1992–
1996 and incidence of BCC 1992–1996 was also investi-
gated. Four arbitrary groups were created to describe
weight change over the period 1992–1996: ≤ -4 kg, -4 kg
to <4 kg, 4 kg to 10 kg, and >10 kg. The reference category
for weight change was -4 kg to 4 kg. Relative risks (RR)
with 95% confidence intervals were calculated using mul-
tivariate Poisson regression, adjusting for age, history of
BCC, weight at baseline, hair colour and eye colour. To
take into account the participants who had withdrawn
without complete skin examination by a dermatologist in
the follow-up period, total person-years were calculated
for each participant, and the log-transformation of this
variable was used as an off-set variable in the model.
Analyses were conducted using SAS (SAS Institute, Cary,
North Carolina, USA).
Results
Of the 1621 people (710 male and 911 female) who
enrolled in the field trial at baseline, 238 participants
(15%) withdrew without complete skin examination by a
dermatologist in the follow-up period. Those with with-
drew without follow-up examination were younger on
average than the remaining participants (mean 47.0 vs
49.1 years), but were similar in all other respects [16]. In
1992 weight was recorded for 1233 participants, and
height for 1112; both weight and height measurements
were available for 1109 participants. Waist circumference
and hip circumference was measured for 1221 partici-
pants, waist-hip ratio able to be calculated for 1220 partic-
ipants. Weight in 1996 was recorded for 1271
participants; weight change 1992–1996 was available for
1079 participants.
Of this population sample, 55% had fair skin, 38%
medium skin and only 7% olive or brown skin (p <
0.001). Most (68%) participants had a skin type that
burned then tanned after acute sun exposure [26]. A high
proportion of the sample (44%) reported that their main
occupation was indoors, but in terms of leisure activities,
only 15% of the sample reported that their main leisure
activity was indoors.
Mean age at baseline was 50.7 years for men and 49.6 for
women. At baseline 94 participants (6%) had a current
BCC; 212 (13%) had been diagnosed with BCC in the
past; and 82 participants (5%) had both a prevalent and a
past history of BCC. During the follow-up period, 179
participants (12%) developed one or more new BCCs (97
(54%) of whom had no previous history of BCC). Of the
women study participants, 1% were underweight
(BMI<18.5), 32% were overweight (BMI 25–29.9), and
17% were obese (BMI ≥ 30). Few males (0.4%) were
underweight, but 48% were overweight and a further 16%
were obese.
Adjusted PPRs of prevalent BCC associated with anthro-
pometric measures are shown in Table 1. For BMI the ref-
erence category was <25 (underweight and normal
categories combined) as there were only 8 individuals in
the underweight category. There was no association
between prevalence of BCC and height for women or
men; the PPR estimates for height were elevated only forBMC Cancer 2006, 6:82 http://www.biomedcentral.com/1471-2407/6/82
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the tallest people, but not significantly. Also no significant
associations were seen between prevalence of BCC and
weight, waist/hip ratio or waist circumference.
Similarly, anthropometric measures were unrelated to
development of new BCCs. Women in the highest quartile
of weight had a small increased risk (RR 1.4, 95% CI 0.9–
2.4), but this was not statistically significant (Table 2). A
separate analysis of incident BCC was performed for par-
ticipants without a history of BCC, however the results did
not differ significantly from those presented.
With respect to short-term weight change and develop-
ment of BCC 1992–1996, weight gain showed a sugges-
tive positive association with BCC for women (Table 2),
but the point estimates were not statistically significant.
Compared with women who gained or lost up to 4 kg, the
risk of developing a BCC during the follow-up period was
Table 1: Height, weight, BMI, waist circumference, waist/hip ratio and risk of BCC at baseline (1992)
Males Females
BCC No BCC PPR (95% CI) a BCC No BCC PPR (95% CI) a
N % N% N%N%
Weight 
quartile
Q1 22 25 109 25 1.0 20 25 152 25 1.0
Q2 22 25 112 25 1.2 (0.7–2.0) 21 26 157 25 0.9 (0.5–1.6)
Q3 26 30 108 24 1.4 (0.8–2.2) 13 16 162 26 0.6 (0.3–1.1)
Q4 17 20 116 26 0.9 (0.5–1.0) 26 33 150 24 1.1 (0.7–1.9)
n = 1223 p = 0.45 p = 0.14
Height 
quartile
Q1 27 34 90 22 1.0 21 29 136 24 1.0
Q2 13 17 100 25 0.6 (0.3–1.1) 19 26 140 25 1.0 (0.6–1.8)
Q3 18 23 111 28 0.8 (0.5–1.3) 12 16 144 26 0.8 (0.4–1.5)
Q4 21 27 100 25 1.3 (0.8–2.1) 21 29 139 25 1.4 (0.8–2.5)




<25 30 38 142 36 1.0 33 45 286 51 1.0
25–29.9 38 48 192 48 1.0 (0.6–1.4) 23 32 179 32 0.9 (0.6–1.5)
≥ 30 11 14 66 17 0.8 (0.4–1.5) 17 23 92 17 1.2 (0.7–2.1)










30 35 114 26 1.3 (0.9–2.0) 49 61 343 43 0.9 (0.6–1.5)
102 + (M); 
88 + (F)
26 30 129 29 1.0 (0.6–1.5) 0 0




≥ 1.0 (M); 
≥ 0.85 (F)
78 90 397 90 1.0 64 80 526 88 1.0
> 1.0 (M); 
> 0.85 (F)
9 10 43 10 0.8 (0.4–1.4) 16 20 87 12 1.0 (0.6–1.7)
n = 1220 p = 0.41 p = 0.90
a Adjusted for age; waist/hip ratio category adjusted for age and skin colourBMC Cancer 2006, 6:82 http://www.biomedcentral.com/1471-2407/6/82
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higher in those who gained 4–10 kg (RR 1.4, 95% CI 0.8–
2.5), and in those who gained 10 kg or more (RR 1.7, 95%
CI 0.5–5.6). For men, the RRs were only slightly elevated
for those who gained 4–10 kg, and again this association
was not statistically significant.
Discussion
The relationship between anthropometric indices and
occurrence of BCC has been little studied. To our knowl-
edge, only two studies have investigated BCC in relation
to anthropometric measures or indices [1,2]. The study by
Milan et al. (2003) did not measure important potential
confounders including phenotypic characteristics or sun
exposure history, and although information on these
potential confounders was collected in the study by Sahl
et al. (1995), they did not consider them in their analyses
which was limited to comparing the mean body weight of
a small number of cases and controls (49 and 46 respec-
tively). Although the current study was also not designed
specifically to examine the association between anthropo-
metric measures and BCC, information on a large number
of other risk factors, including phenotypic characteristics
and sun exposure history, was collected and these risk fac-
tors were assessed as possible confounders in the relation-
ship between BCC and anthropometric measures.
In the present large prospective study, there were no sig-
nificant associations between any of the anthropometric
measures or indices and BCC, though a suggestive positive
association between short term weight gain and develop-
ment of BCC in women was observed. This implies that a
stable body weight may be more favourable with respect
to the development of BCC then short-term changes in
body weight in this study population. It is unclear why
weight gain might be associated with the development of
BCC. Weight gain is a consequence of higher energy
intake than energy expenditure over time, and availability
or restriction of energy can modulate the cellular replica-
tion process. There is evidence from studies of different
animal models that suggests caloric restriction inhibits
cell proliferation [27] and carcinogenesis [28,29]. One
study in human subjects also supported this hypothesis
[10]. These data have been further supported by recent
epidemiological studies that demonstrate the importance
of energy balance and obesity in human cancer [3,5,30-
32].
The association between weight gain and BCC, if con-
firmed by other studies, may be mediated via alterations
in the metabolism of endogenous hormones (sex steroids,
insulin and insulin-like growth factors) (that lead to a
change in the normal balance between cell proliferation,
differentiation and apoptosis [11,12,33]), or through
reduction in immunity [14], although this hypothesis is
based on results of animal studies.
For weight and BMI at baseline, no association was
observed. Some research has suggested that adult weight
gain may be a better variable to assess adiposity and its
metabolic consequences than body weight itself [33],
since weight gain largely reflects an increase in body fat,
whereas weight reflects both lean and fat body mass.
Height seemed to be associated inconsistently with an
increased risk of developing BCC, but the point estimates
were not significant, and there were no significant tests for
trend. Tallness has been associated with increased risk of
a number of other cancers, including cancers of the breast,
colon, and prostate [3-5] and the same biological mecha-
nisms as described above for weight gain have been pro-
posed to explain these associations. It may also be
possible that there is some behavioural correlate of body
height related to sun exposure, such as participation in
outdoor sporting activities [34], that increases the likeli-
hood of developing BCC.
Strengths of this study include its large population sample
with a high participation rate as well as its prospective
design, and the ability to assess a large number of other
risk factors as possible confounders of the association
between anthropometric measures and BCC. Standard-
ised methods for measuring weight and height, and com-
prehensive data on BCC incidence from 1992 -1996 were
also features of this investigation. Our large prospective
study did not have the limitations of the previous two
studies. The case-control study by Sahl et al. (1995) was
based on a very small number of clinic-based cases of BCC
(less than 50), and thus it was limited in power, suscepti-
ble to selection bias due to non-representative cases and
controls and to faulty recall of past weight and height
measurements. Indeed both previous studies relied upon
self-reported weight and height measurements. In the sec-
ond study by Milan et al. (2003), subjects were drawn
from a twin cohort and a single self-reported weight was
the basis of their assessment of BMI in relation to incident
BCC over the next 23 years. That is, no account of weight
change or assessment of latent effect of BMI on disease
was possible. Our study reported here was a prospective,
population-based study of anthropometric measures and
BCC and thus susceptible to neither recall nor selection
biases. It is the first study to have used objectively meas-
ured height and weight, together with measured waist and
hip circumference in relation to BCC, and the only study
to have examined weight change. Also the potential influ-
ences of most known risk factors for BCC were thoroughly
assessed.
Limitations of the study include reliance on self-report of
BCC prior to 1986, and availability of only a single height
measurement in 1992. In older adults (age 60+), height
can decrease with age due to spinal deformity and thin-
ning of the intervertebral discs [35]. This decrease inBMC Cancer 2006, 6:82 http://www.biomedcentral.com/1471-2407/6/82
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RR (95% CI) a BCC No 
BCC
RR (95% CI) a
N% N % N % N %
Weight quartile
Q1 23 30 97 24 1.0 17 21 141 25 1.0
Q2 15 20 107 26 0.7 (0.5–1.1) 19 24 146 26 1.1 (0.6–1.8)
Q3 21 28 100 24 0.9 (0.6–1.3) 17 21 152 27 0.9 (0.5–1.5)
Q4 17 22 106 26 1.0 (0.6–1.5) 27 34 131 23 1.4 (0.9–2.4)
n = 1223 p = 0.29 p = 0.22
Height quartile
Q1 18 27 84 23 1.0 19 25 125 24 1.0
Q2 15 23 92 25 1.3 (0.8–2.1) 20 27 127 25 1.0 (0.6–1.6)
Q3 21 32 98 26 1.5 (1.0–2.3) 16 21 133 26 1.0 (0.6–1.7)
Q4 12 18 97 26 0.9 (0.6–1.4) 20 27 127 25 1.3 (0.8–2.3)
n = 1112 p = 0.16 p = 0.62
BMI category (kg/m2)
<25 23 35 131 35 1.0 35 47 262 51 1.0
25–29.9 34 52 178 48 0.9 (0.6–1.4) 26 35 166 33 0.7 (0.5–1.1)
 30 9 14 61 17 1.0 (0.6–1.7) 14 19 82 16 1.2 (0.7–2.0)
n = 1109 p = 0.94 p = 0.15
Waist category (cm)
<94 (M); <80 (F) 27 36 182 45 1.0 26 33 252 45 1.0
94–101.9 (M); 80–87.9 (F) 25 33 106 26 0.9 (0.6–1.3) 53 67 312 55 1.0 (0.8–1.4)
102 + (M); 88 + (F) 24 32 117 29 1.0 (0.6–1.5) 0 0
n = 1221 p = 0.83 p = 0.71
Waist/hip ratio category
 1.0 (M);  0.85 (F) 69 91 365 90 1.0 63 80 485 86 1.0
> 1.0 (M); > 0.85 (F) 7 9 40 10 0.9 (0.5–1.5) 16 20 78 14 1.1 (0.7–1.7)
n = 1220 p = 0.53 p = 0.85
Weight change (kg)
<-4 10 14 29 18 1.2 (0.6–2.5) 14 19 44 9 1.5 (0.8–2.7)
-4–3.9 48 66 232 65 1.0 37 51 311 62 1.0
4–10 15 21 85 24 1.1 (0.6–1.9) 18 25 115 23 1.4 (0.8–2.5)
10+ 0 0 13 4 4 6 29 6 1.7 (0.5–5.6)
n = 1004 p = 0.63 p = 0.52
a Adjusted for age, and history of BCC 
Weight quartile and waist circumference category adjusted for age, history of BCC and hair colour 
Height quartile and BMI category adjusted for age, history of BCC and eye colour 
Weight change category adjusted for age, history of BCC, weight at baseline, hair and eye colour
height has been reported to range from 0.5–1.5 cm/dec-
ade [35], to 2.5–5 cm/decade [36]. We could therefore
expect that there would have been some change in height
for the 26.9% of study participants aged over 60 years (in
1992), however we would expect this change in height to
be modest over the 4.5 year follow-up period.
Conclusion
Adherence to WHO guidelines for BMI, waist circumfer-
ence, waist/hip ratio appears not to be associated with
occurrence of BCC, though there may be a positive associ-
ation between weight gain and occurrence of BCC in
women that warrants further investigation.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
CO performed the statistical analysis, and drafted the
manuscript. AG participated in the design and coordina-
tion of the study. CO, AG and MH were involved in criti-BMC Cancer 2006, 6:82 http://www.biomedcentral.com/1471-2407/6/82
Page 7 of 7
(page number not for citation purposes)
cally revising the manuscript. NP advised on statistical
analysis and interpretation of the data. All authors read
and approved the final manuscript.
Acknowledgements
We thank the participants from the Nambour community for their long-
standing dedication and commitment. This study was supported by the 
National Health and Medical Research Council of Australia. Maria Celia 
Hughes was funded by the World Cancer Research Fund International.
References
1. Sahl WJ, Glore S, Garrison P, Oakleaf K, Johnson SD: Basal cell car-
cinoma and lifestyle characteristics.  Int J Dermatol 1995,
34(6):398-402.
2. Milan T, Verkasalo PK, Kaprio J, Koskenvuo M: Lifestyle differ-
ences in twin pairs discordant for basal cell carcinoma of the
skin.  Br J Dermatol 2003, 149(1):115-123.
3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight,
obesity, and mortality from cancer in a prospectively studied
cohort of U.S. adults.  N Engl J Med 2003, 348(17):1625-1638.
4. Hebert PR, Ajani U, Cook NR, Lee IM, Chan KS, Hennekens CH:
Adult height and incidence of cancer in male physicians
(United States).  Cancer Causes Control 1997, 8(4):591-597.
5. Albanes D, Jones DY, Schatzkin A, Micozzi MS, Taylor PR: Adult
stature and risk of cancer.  Cancer Res 1988, 48(6):1658-1662.
6. Bianchini F, Kaaks R, Vainio H: Overweight, obesity, and cancer
risk.  Lancet Oncol 2002, 3(9):565-574.
7. Albanes D, Winick M: Are cell number and cell proliferation
risk factors for cancer?  J Natl Cancer Inst 1988, 80(10):772-774.
8. Ross MH, Bras G: Tumor incidence patterns and nutrition in
the rat.  J Nutr 1965, 87(3):245-260.
9. Ross MH, Bras G: Lasting influence of early caloric restriction
on prevalence of neoplasms in the rat.  J Natl Cancer Inst 1971,
47(5):1095-1113.
10. Frankel S, Gunnell DJ, Peters TJ, Maynard M, Davey Smith G: Child-
hood energy intake and adult mortality from cancer: the
Boyd Orr Cohort Study.  Bmj 1998, 316(7130):499-504.
11. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J,
Skakkebaek NE: Serum levels of insulin-like growth factor
(IGF)-binding protein-3 (IGFBP-3) in healthy infants, chil-
dren, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1,
IGFBP-2, age, sex, body mass index, and pubertal matura-
tion.  J Clin Endocrinol Metab 1995, 80(8):2534-2542.
12. Henderson BE, Ross RK, Pike MC, Casagrande JT: Endogenous hor-
mones as a major factor in human cancer.  Cancer Res 1982,
42(8):3232-3239.
13. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U: Impact of obesity
on metabolism in men and women. Importance of regional
adipose tissue distribution.  J Clin Invest 1983, 72(3):1150-1162.
14. Scrimshaw NS, SanGiovanni JP: Synergism of nutrition, infection,
and immunity: an overview.  Am J Clin Nutr 1997,
66(2):464S-477S.
15. Green A, Battistutta D, Hart V, Leslie D, Marks G, Williams G, Gaff-
ney P, Parsons P, Hirst L, Frost C, et al.: The Nambour Skin Can-
cer and Actinic Eye Disease Prevention Trial: design and
baseline characteristics of participants.  Control Clin Trials 1994,
15(6):512-522.
16. Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, Marks GC,
Gaffney P, Battistutta D, Frost C, Lang C, Russell A: Daily sunscreen
application and betacarotene supplementation in preven-
tion of basal-cell and squamous-cell carcinomas of the skin: a
randomised controlled trial.  Lancet 1999, 354(9180):723-729.
17. Green A, Beardmore G, Hart V, Leslie D, Marks R, Staines D: Skin
cancer in a Queensland population.  J Am Acad Dermatol 1988,
19(6):1045-1052.
18. Green A, Battistutta D: Incidence and determinants of skin can-
cer in a high-risk Australian population.  Int J Cancer 1990,
46(3):356-361.
19. Green A, Battistutta D, Hart V, Leslie D, Weedon D: Skin cancer in
a subtropical Australian population: incidence and lack of
association with occupation. The Nambour Study Group.
Am J Epidemiol 1996, 144(11):1034-1040.
20. Physical status: the use and interpretation of anthropome-
try. Report of a WHO Expert Committee.  World Health Organ
Tech Rep Ser 1995, 854:1-452.
21. Obesity: preventing and managing the global epidemic.
Report of a WHO consultation.  World Health Organ Tech Rep Ser
2000, 894:i-xii, 1-253.
22. Han TS, Seidell JC, Currall JE, Morrison CE, Deurenberg P, Lean ME:
The influences of height and age on waist circumference as
an index of adiposity in adults.  Int J Obes Relat Metab Disord 1997,
21(1):83-89.
23. Skov T, Deddens J, Petersen MR, Endahl L: Prevalence proportion
ratios: estimation and hypothesis testing.  Int J Epidemiol 1998,
27(1):91-95.
24. Zou G: A modified poisson regression approach to prospec-
tive studies with binary data.  Am J Epidemiol 2004,
159(7):702-706.
25. Greenland S, Rothman KJ: Introduction to stratified analysis.  In
Modern Epidemiology Edited by: Rothman KJ, Greenland S. Philadelphia
, Lippincott-Raven; 1998:253-281. 
26. Valery PC, Neale R, Williams G, Pandeya N, Siller G, Green A: The
effect of skin examination surveys on the incidence of basal
cell carcinoma in a Queensland community sample: a 10-
year longitudinal study.  J Investig Dermatol Symp Proc 2004,
9(2):148-151.
27. Turturro A, Blank K, Murasko D, Hart R: Mechanisms of caloric
restriction affecting aging and disease.  Ann N Y Acad Sci 1994,
719:159-170.
28. Birt DF, Pelling JC, White LT, Dimitroff K, Barnett T: Influence of
diet and calorie restriction on the initiation and promotion
of skin carcinogenesis in the SENCAR mouse model.  Cancer
Res 1991, 51(7):1851-1854.
29. Birt DF, Przybyszewski J, Wang W, Stewart J, Liu Y: Identification
of molecular targets for dietary energy restriction preven-
tion of skin carcinogenesis: an idea cultivated by Edward
Bresnick.  J Cell Biochem 2004, 91(2):258-264.
30. Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE:
Obesity, recreational physical activity, and risk of pancreatic
cancer in a large u.s. Cohort.  Cancer Epidemiol Biomarkers Prev
2005, 14(2):459-466.
31. Ross JA, Parker E, Blair CK, Cerhan JR, Folsom AR: Body mass
index and risk of leukemia in older women.  Cancer Epidemiol
Biomarkers Prev 2004, 13(11 Pt 1):1810-1813.
32. Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ: Body mass
index and colon cancer mortality in a large prospective
study.  Am J Epidemiol 2000, 152(9):847-854.
33. McCullough ML, Giovannucci EL: Diet and cancer prevention.
Oncogene 2004, 23(38):6349-6364.
34. Norton K, Olds T: Morphological evolution of athletes over
the 20th century: causes and consequences.  Sports Med 2001,
31(11):763-783.
35. Baumgartner RN, Stauber PM, McHugh D, Koehler KM, Garry PJ:
Cross-sectional age differences in body composition in per-
sons 60+ years of age.  J Gerontol A Biol Sci Med Sci 1995,
50(6):M307-16.
36. de Groot CP, Perdigao AL, Deurenberg P: Longitudinal changes in
anthropometric characteristics of elderly Europeans.
SENECA Investigators.  Eur J Clin Nutr 1996, 50 Suppl 2:S9-15.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2407/6/82/prepub